Life (Jan 2022)

Biomarker Potential of Vimentin in Oral Cancers

  • Saie Mogre,
  • Vidhi Makani,
  • Swapnita Pradhan,
  • Pallavi Devre,
  • Shyam More,
  • Milind Vaidya,
  • Crismita Dmello

DOI
https://doi.org/10.3390/life12020150
Journal volume & issue
Vol. 12, no. 2
p. 150

Abstract

Read online

Oral carcinogenesis is a multistep process. As much as 5% to 85% of oral tumors can develop from potentially malignant disorders (PMD). Although the oral cavity is accessible for visual examination, the ability of current clinical or histological methods to predict the lesions that can progress to malignancy is limited. Thus, developing biological markers that will serve as an adjunct to histodiagnosis has become essential. Our previous studies comprehensively demonstrated that aberrant vimentin expression in oral premalignant lesions correlates to the degree of malignancy. Likewise, overwhelming research from various groups show a substantial contribution of vimentin in oral cancer progression. In this review, we have described studies on vimentin in oral cancers, to make a compelling case for vimentin as a prognostic biomarker.

Keywords